A groundbreaking study has uncovered how specific genetic mutations influence cancer treatment outcomes — insights that could help doctors tailor treatments more effectively. The largest study of its kind, the research analyzed data for more than 78,000 cancer patients across 20 cancer types. Patients received immunotherapies, chemotherapies and targeted therapies.
